Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3479376 | 0.89 | ALOX5 (0.62) | ALOX5SMN1; SMN2ALDH1A1TRPA1CYP3A4 | |
| SCHEMBL4937028 | 0.84 | — | — | |
| SCHEMBL293786 | 0.82 | — | — | |
| SCHEMBL1977937 | 0.82 | — | — | |
| SCHEMBL3479153 | 0.80 | ALOX5 (0.59) | ALOX5SMN1; SMN2ALDH1A1TRPA1CYP3A4 | |
| SCHEMBL4157460 | 0.80 | ALOX5 (0.59) | ALOX5SMN1; SMN2ALDH1A1TRPA1CYP3A4 | |
| SCHEMBL3479692 | 0.80 | ALOX5 (0.59) | ALOX5SMN1; SMN2ALDH1A1TRPA1CYP3A4 | |
| SCHEMBL23034161 | 0.80 | TSHR (0.48) | ALOX5SMN1; SMN2TSHRALDH1A1TRPA1 | |
| SCHEMBL12231752 | 0.80 | TSHR (0.48) | ALOX5SMN1; SMN2TSHRALDH1A1TRPA1 | |
| SCHEMBL11519491 | 0.80 | TSHR (0.48) | ALOX5SMN1; SMN2TSHRALDH1A1TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7550606-B2 | 9-cyano-substituted perylene-3,4-dicarboxylic acid monoimides | BASF AKTIENGESELLSCHAFT (DE) | 2009-06-23 | — | — | US | disclosed |
| US-20090023937-A1 | 9-CYANO-SUBSTITUTED PERYLENE-3,4-DICARBOXYLIC ACID MONOIMIDES | BASF AKTIENGESELLSCHAFT (DE) | 2009-01-22 | — | — | US | disclosed |
| US-7446198-B2 | 9-Cyano-substituted perylene-3, 4-dicarboxylic monoimides | BASF AKTIENGESELLSCHAFT (DE) | 2008-11-04 | — | — | US | disclosed |
| US-20060229385-A1 | 9-Cyano-Substituted Perylene-3, 4-Dicarboxylic Monoimides | BASF AKTIENGESELLSCHAFT (DE) | 2006-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090023937-A1 | 9-CYANO-SUBSTITUTED PERYLENE-3,4-DICARBOXYLIC ACID MONOIMIDES | CA9, F9, CA13 | ALOX5 3358/4885SMN1; SMN2 4425/4885TSHR 4512/4885 |
| US-20060229385-A1 | 9-Cyano-Substituted Perylene-3, 4-Dicarboxylic Monoimides | CBR3, NR2C2, NR0B2 | ALOX5 632/4885SMN1; SMN2 3831/4885TSHR 531/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.